UC Irvine Study Finds Popular Weight Loss Medication May Benefit 93 Million U.S. Adults
A projected 93 million U.S. adults who are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy, a University of California, Irvine study has found.The!-->…